• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较效果研究的评估:一种实用工具。

Evaluation of comparative effectiveness research: a practical tool.

作者信息

Schaumberg Debra A, McDonald Laura, Shah Surbhi, Stokes Michael, Nordstrom Beth L, Ramagopalan Sreeram V

机构信息

Real-World Evidence, Evidera, Waltham, MA 02451, USA.

Center for Observational Research & Data Sciences, Bristol-Myers Squibb, Uxbridge, UB8 1DH, UK.

出版信息

J Comp Eff Res. 2018 May;7(5):503-515. doi: 10.2217/cer-2018-0007. Epub 2018 Feb 21.

DOI:10.2217/cer-2018-0007
PMID:29463115
Abstract

Comparative effectiveness research (CER) guidelines have been developed to direct the field toward the most rigorous study methodologies. A challenge, however, is how to ensure the best evidence is generated, and how to translate methodologically complex or nuanced CER findings into usable medical evidence. To reach that goal, it is important that both researchers and end users of CER output become knowledgeable about the elements that impact the quality and interpretability of CER. This paper distilled guidance on CER into a practical tool to assist both researchers and nonexperts with the critical review and interpretation of CER, with a focus on issues particularly relevant to CER in oncology.

摘要

比较效果研究(CER)指南已经制定出来,以引导该领域采用最严格的研究方法。然而,一个挑战是如何确保产生最佳证据,以及如何将方法复杂或细微差别的CER结果转化为可用的医学证据。为了实现这一目标,CER产出的研究人员和最终用户都了解影响CER质量和可解释性的因素非常重要。本文将CER指南提炼成一个实用工具,以协助研究人员和非专家对CER进行批判性审查和解释,重点关注肿瘤学中与CER特别相关的问题。

相似文献

1
Evaluation of comparative effectiveness research: a practical tool.比较效果研究的评估:一种实用工具。
J Comp Eff Res. 2018 May;7(5):503-515. doi: 10.2217/cer-2018-0007. Epub 2018 Feb 21.
2
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
3
Overview of best practices in conducting comparative-effectiveness reviews.开展药物经济学评价的最佳实践概述。
Clin Pharmacol Ther. 2011 Dec;90(6):876-82. doi: 10.1038/clpt.2011.239. Epub 2011 Nov 2.
4
Comparative effectiveness research paradigm: implications for systematic reviews and clinical practice guidelines.比较效力研究范式:对系统评价和临床实践指南的启示。
J Clin Oncol. 2012 Dec 1;30(34):4202-7. doi: 10.1200/JCO.2012.42.1644. Epub 2012 Oct 15.
5
Comparative effectiveness research: moving medical oncology forward.比较疗效研究:推动医学肿瘤学发展。
Semin Radiat Oncol. 2014 Jan;24(1):49-53. doi: 10.1016/j.semradonc.2013.08.005.
6
Got CER? Educating Pharmacists for Practice in the Future: New Tools for New Challenges.有 CER 吗?为未来的实践培养药剂师:新挑战的新工具。
J Manag Care Spec Pharm. 2016 Jun;22(6):609-16. doi: 10.18553/jmcp.2016.22.6.609.
7
Comparative effectiveness research methodology using secondary data: A starting user's guide.使用二手数据的比较效果研究方法:入门指南。
Urol Oncol. 2018 Apr;36(4):174-182. doi: 10.1016/j.urolonc.2017.10.011. Epub 2017 Nov 13.
8
Comparative effectiveness research: opportunities in surgical oncology.比较疗效研究:外科肿瘤学的机遇。
Semin Radiat Oncol. 2014 Jan;24(1):43-8. doi: 10.1016/j.semradonc.2013.09.003.
9
It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.需要注意的是,真实世界数据(RWD)永远无法取代更为传统且更为可靠的随机对照试验(RCT)数据;然而,新出现的趋势是纳入更具普遍性的数据。引言。
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl A):S03-4.
10
Evidence gaps in advanced cancer care: community-based clinicians' perspectives and priorities for CER.晚期癌症护理中的证据差距:基于社区的临床医生对转化研究的观点和优先事项。
Am J Manag Care. 2012 May;18(5 Spec No. 2):SP77-83.

引用本文的文献

1
APPRAISE: A Tool for Appraising Potential for Bias in Real-world Evidence Studies on Medication Effectiveness or Safety.APPRAISE:一种评估药物有效性或安全性真实世界证据研究中偏倚可能性的工具。
Value Health. 2025 Aug 5. doi: 10.1016/j.jval.2025.07.024.
2
Psychosocial Interventions in the Rehabilitation and the Management of Psychosis and Schizophrenia: A Systematic Review on Digitally-Delivered Interventions.精神病和精神分裂症康复与管理中的心理社会干预:关于数字交付干预的系统评价
Actas Esp Psiquiatr. 2025 Mar;53(2):379-421. doi: 10.62641/aep.v53i2.1851.
3
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations.
嵌合抗原受体 T 细胞疗法治疗多发性骨髓瘤的疗效比较研究:适当的比较需要仔细考虑数据来源和患者人群。
Clin Drug Investig. 2021 Mar;41(3):201-210. doi: 10.1007/s40261-021-01012-x. Epub 2021 Feb 18.
4
Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making.真实世界数据:为医疗保健决策中使用长期存在的药物补充现有证据的一个机会。
J Multidiscip Healthc. 2018 Jul 2;11:295-304. doi: 10.2147/JMDH.S160029. eCollection 2018.